Treating pediatric nonalcoholic fatty liver disease with cysteamine: is adiponectin the key?
Stavra A
SA
Xanthakos
Rohit
R
Kohli
D052242:Adiponectin / Q000737:chemistry*; D003543:Cysteamine / Q000494:pharmacology*; D006801:Humans; D055503:Protein Multimerization / Q000187:drug effects*
D052242:Adiponectin; D003543:Cysteamine